MCID: BRS067
MIFTS: 14

Breast Cancer, Childhood

Categories: Rare diseases, Cancer diseases

Aliases & Classifications for Breast Cancer, Childhood

MalaCards integrated aliases for Breast Cancer, Childhood:

Name: Breast Cancer, Childhood 50
Childhood Breast Cancer 50

Classifications:



Summaries for Breast Cancer, Childhood

NIH Rare Diseases : 50 this condition doesn't have a summary yet. please see our page(s) on familial breast cancer.

MalaCards based summary : Breast Cancer, Childhood, is also known as childhood breast cancer. An important gene associated with Breast Cancer, Childhood is IGF2 (Insulin Like Growth Factor 2). The drugs Cyclophosphamide and Palivizumab have been mentioned in the context of this disorder. Affiliated tissues include breast, bone and bone marrow.

Related Diseases for Breast Cancer, Childhood

Symptoms & Phenotypes for Breast Cancer, Childhood

Drugs & Therapeutics for Breast Cancer, Childhood

Drugs for Breast Cancer, Childhood (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 131)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 3,Phase 1,Phase 2 50-18-0, 6055-19-2 2907
2
Palivizumab Approved, Investigational Phase 3 188039-54-5
3
Ribavirin Approved Phase 3 36791-04-5 37542
4
Fluconazole Approved Phase 3 86386-73-4 3365
5
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
6
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
7
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
8
Captopril Approved Phase 3 62571-86-2 44093
9
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 1,Phase 2 128794-94-5 5281078
10
Mycophenolic acid Approved Phase 3,Phase 1,Phase 2 24280-93-1 446541
11 Alkylating Agents Phase 3,Phase 1,Phase 2
12 Antirheumatic Agents Phase 3,Phase 1,Phase 2
13 Immunosuppressive Agents Phase 3,Phase 1,Phase 2
14 Antibodies Phase 3,Phase 1
15 Antibodies, Monoclonal Phase 3,Phase 1
16 Anti-Infective Agents Phase 3,Phase 1,Phase 2
17 Antimetabolites Phase 3,Phase 1,Phase 2
18 Antiviral Agents Phase 3,Phase 2
19 Immunoglobulins Phase 3,Phase 1
20 Antifungal Agents Phase 3,Phase 1,Phase 2
21 Cytochrome P-450 CYP2C9 Inhibitors Phase 3
22 Cytochrome P-450 CYP3A Inhibitors Phase 3
23 Cytochrome P-450 Enzyme Inhibitors Phase 3
24 Hormone Antagonists Phase 3,Phase 1,Phase 2
25 Hormones Phase 3,Phase 1,Phase 2
26 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 1,Phase 2
27 Hydroxyitraconazole Phase 3
28 Steroid Synthesis Inhibitors Phase 3
29 Acyclovir Phase 3
30 valacyclovir Phase 3
31 Anti-Bacterial Agents Phase 3,Phase 1,Phase 2
32 Antiparasitic Agents Phase 3
33 Antiprotozoal Agents Phase 3
34 Liposomal amphotericin B Phase 3
35 Angiotensin-Converting Enzyme Inhibitors Phase 3
36 Antihypertensive Agents Phase 3,Phase 1
37 HIV Protease Inhibitors Phase 3
38
protease inhibitors Phase 3
39 Antibiotics, Antitubercular Phase 3,Phase 1,Phase 2
40
Lenograstim Approved Phase 2 135968-09-1
41
Oprelvekin Approved, Investigational Phase 2 145941-26-0
42
Fludarabine Approved Phase 1, Phase 2 21679-14-1, 75607-67-9 30751
43
Busulfan Approved, Investigational Phase 2 55-98-1 2478
44
Carboplatin Approved Phase 2 41575-94-4 10339178 498142 38904
45
Carmustine Approved Phase 2 154-93-8 2578
46
Etoposide Approved Phase 2 33419-42-0 36462
47
Melphalan Approved Phase 2 148-82-3 4053 460612
48 Thiotepa Approved Phase 2 52-24-4 5453
49
alemtuzumab Approved, Investigational Phase 2 216503-57-0
50
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741

Interventional clinical trials:

(show all 44)

id Name Status NCT ID Phase Drugs
1 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
2 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
3 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
4 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
5 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
6 Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer Active, not recruiting NCT01579552 Phase 3
7 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
8 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
9 Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer Completed NCT00365287 Phase 1, Phase 2 anti-thymocyte globulin;cyclophosphamide;cyclosporine;fludarabine phosphate;mycophenolate mofetil
10 High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors Completed NCT00060255 Phase 2 busulfan;carboplatin;carmustine;cyclophosphamide;etoposide;melphalan;thiotepa
11 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
12 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
13 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
14 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
15 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
16 Chemotherapy in Treating Patients With Solid Tumors Completed NCT00003103 Phase 1, Phase 2 docetaxel
17 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
18 Radiotherapy Delivery in Deep Inspiration for Pediatric Patients Recruiting NCT03315546 Phase 1, Phase 2
19 Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Active, not recruiting NCT01492673 Phase 2 Cyclophosphamide, Topotecan, and Bevacizumab
20 The Effect of Soy Protein on Post- Breast Cancer Surgery Pain Terminated NCT01047774 Phase 2
21 Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant Withdrawn NCT00728585 Phase 2
22 Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections Unknown status NCT00769613 Phase 1
23 Vaccine Therapy in Treating Patients With Metastatic Cancer Completed NCT00020267 Phase 1 interleukin-2;MAGE-12 peptide vaccine;Montanide ISA-51
24 Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer Completed NCT00060372 Phase 1 ipilimumab;therapeutic allogeneic lymphocytes
25 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
26 Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor Completed NCT00161187 Phase 1
27 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Completed NCT00509691 Phase 1
28 Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant Completed NCT00569283 Phase 1
29 Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors Not yet recruiting NCT02897986 Phase 1 administration of a propranolol (HEMANGIOL®) and oral metronomic vinorelbine (NAVELBINE®) combination
30 Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00957736 Phase 1
31 Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Unknown status NCT00499733 cyclophosphamide
32 Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women Completed NCT00559039
33 Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study Completed NCT01365975
34 Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant Completed NCT00408681 lithium carbonate
35 Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Completed NCT00079222 itraconazole;voriconazole
36 Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation Completed NCT00003538
37 National Breast and Thyroid Screening After a Treatment Received Against a Cancer During Childhood Recruiting NCT03183401
38 Smart Adult Living After Childhood Cancer (SmartALACC) Online Care Plans: Feasibility and Patient Satisfaction Recruiting NCT02559219
39 Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation Recruiting NCT02664389
40 Familial Investigations of Childhood Cancer Predisposition Recruiting NCT03050268
41 Assessment of Ovarian Reserve in Female Cancer Survivors Active, not recruiting NCT01062542
42 Rehabilitation of Cognitive Changes in Breast Cancer Survivors Active, not recruiting NCT01182506
43 Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer Active, not recruiting NCT00949052
44 Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection Withdrawn NCT00378781 Heparin;Minocycline-EDTA

Search NIH Clinical Center for Breast Cancer, Childhood

Genetic Tests for Breast Cancer, Childhood

Anatomical Context for Breast Cancer, Childhood

MalaCards organs/tissues related to Breast Cancer, Childhood:

39
Breast, Bone, Bone Marrow, Thyroid, Liver, Colon, Kidney

Publications for Breast Cancer, Childhood

Variations for Breast Cancer, Childhood

Expression for Breast Cancer, Childhood

Search GEO for disease gene expression data for Breast Cancer, Childhood.

Pathways for Breast Cancer, Childhood

GO Terms for Breast Cancer, Childhood

Sources for Breast Cancer, Childhood

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....